LEADER 01315nam--2200373---450- 001 990001745170203316 005 20060112152131.0 035 $a000174517 035 $aUSA01000174517 035 $a(ALEPH)000174517USA01 035 $a000174517 100 $a20040610d1980----km-y0itay0103----ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aRimedi per la sonn$fLotto Lotti$gtesto critico, traduzioni e note di Maria Grazia Accorsi 210 $aBologna$cCommissione per i testi di lingua$d1980 215 $aLXXI, 360 p.$d17 cm 225 2 $aScelta di curiosità letterarie inedite o rare dal secolo 13. al 19. in appendice alla Collezione di opere inedite o rare$v273 410 0$12001$aScelta di curiosità letterarie inedite o rare dal secolo 13. al 19. in appendice alla Collezione di opere inedite o rare$v273 454 1$12001 461 1$1001-------$12001 676 $a852.5 700 1$aLOTTI,$bLotto$0384342 702 1$aACCORSI,$bMaria Grazia 801 0$aIT$bsalbc$gISBD 912 $a990001745170203316 951 $aVI.3. Coll.14/ 125(V A 400/273)$b8497 L.M.$cV A 959 $aBK 969 $aUMA 979 $aSIAV4$b10$c20040610$lUSA01$h1712 979 $aCOPAT2$b90$c20060112$lUSA01$h1521 996 $aRimedi per la sonn$9472839 997 $aUNISA LEADER 05601nam 22006615 450 001 9910300210103321 005 20250709140227.0 010 $a1-4939-1881-8 024 7 $a10.1007/978-1-4939-1881-2 035 $a(CKB)3710000000281082 035 $a(EBL)1964963 035 $a(OCoLC)907301155 035 $a(SSID)ssj0001386595 035 $a(PQKBManifestationID)11814663 035 $a(PQKBTitleCode)TC0001386595 035 $a(PQKBWorkID)11374315 035 $a(PQKB)10189863 035 $a(DE-He213)978-1-4939-1881-2 035 $a(MiAaPQ)EBC1964963 035 $a(PPN)183088867 035 $a(EXLCZ)993710000000281082 100 $a20141117d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aManagement of Bladder Cancer $eA Comprehensive Text With Clinical Scenarios /$fedited by Badrinath R. Konety, Sam S. Chang 205 $a1st ed. 2015. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2015. 215 $a1 online resource (474 p.) 300 $aDescription based upon print version of record. 311 08$a1-4939-1880-X 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aEpidemiology and natural history -- Screening for Bladder Cancer -- Pathology and Staging: Histopathology and Cytopathology -- Pathology and Staging: Genetics and Molecular Biology -- Imaging in Localized and Advanced Bladder Cancer -- New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder -- Socioeconomic issues and improved quality of care -- Quality of life measures -- Prognostication and risk assessment -- Clinical trials and emerging therapeutic strategies in bladder cancer -- Improved diagnostic techniques -- Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging -- Localized surgical therapy and surveillance -- Clinical Scenario: Initial high grade Ta tumor -- Clinical Scenario: Recurrent Ta tumor -- Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor -- Clinical Scenario: Low grade T1 tumor -- Intravesical therapy -- Clinical Scenario: Initial CIS -- Management of BCG Recurrent Bladder Cancer -- Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG -- Maurizio Brausi -- Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation -- Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines -- Open Radical Cystectomy -- Robotic cystectomy -- Clinical Scenario: T2 bladder tumor -- Urinary Diversion: Open and robotic techniques -- Chemoradiotherapy -- Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation -- Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application -- Clinical Scenario: Large volume, non metastatic T2 bladder tumor -- The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer -- Clinical Scenario: Unexpected positive nodes at radical cystectomy -- Surveillance andmonitoring -- Clinical Scenario: The Role of Perioperative Chemotherapy -- Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy -- Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU. 330 $aThis book provides a single, comprehensive reference source that incorporates the epidemiology, natural history, and the latest genetic and molecular biological findings of bladder cancer. This book discusses the diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer and incorporates the new findings on markers for the diagnosis of bladder cancer. Risk stratified treatment of non-muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline-based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. This book covers the application of chemotherapy for muscle invasive and advanced disease. The evidence-based application of multimodality therapy is highlighted. Gaps in current knowledge and important areas for clinical  research are highlighted. Authored by experts in their respective fields, Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios serves as an easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology. 606 $aUrology 606 $aOncology 606 $aInterventional radiology 606 $aUrology 606 $aOncology 606 $aInterventional Radiology 615 0$aUrology. 615 0$aOncology. 615 0$aInterventional radiology. 615 14$aUrology. 615 24$aOncology. 615 24$aInterventional Radiology. 676 $a610 676 $a616.0757 676 $a616.6 676 $a616994 702 $aKonety$b Badrinath R$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aChang$b Sam S$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300210103321 996 $aManagement of Bladder Cancer$91867671 997 $aUNINA